Skip to content

The Prevalence of Sarcopenia in a Cohort of Haemodialysis Patients and Its Correlation With Mortality

The Prevalence of Sarcopenia in a Cohort of Patients With End Stage Kidney Disease on Haemodialysis Patients and Its Correlation With Mortality

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06477978
Enrollment
274
Registered
2024-06-27
Start date
2021-02-15
Completion date
2023-03-15
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis Dependent Chronic Kidney Disease, End-stage Kidney Disease, End-stage Renal Disease, Sarcopenia

Keywords

sarcopenia, end stage renal disease, end stage kidney disease, dialysis dependent end stage renal disease

Brief summary

The study aims to explore the correlation between the prevalence of sarcopenia and one year mortality amongst patients on maintenance hemodialysis

Detailed description

In our study , we aim to explore the correlation between the prevalence of sarcopenia and one year mortality among patients on maintenance hemodialysis The lean muscle mass was measured using bio-impedance analysis (BIA ). The hand-grip test was used to measure the function . Sarcopenia was defined using European Working Group on Sarcopenia in Older people (EWGSOP) definition which involves reduced muscle function and reduced muscle mass

Interventions

DIAGNOSTIC_TESTHand grip function testing

The use of Bio-impedance to measure the skeletal muscle mass

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

This is cohort prospective study of end stage kidney disease patients on hemodialysis

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with End stage kidney disease on maintenance dialysis

Exclusion criteria

* unable to consent or terminal malignancy

Design outcomes

Primary

MeasureTime frameDescription
One year mortalityOne yearAll cause mortality of patients with end stage kidney disease on hemodialysis

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026